An interventional study of colonoscopy in Screening Colonoscopy, Colonoscopic Control After Polypectomy and Suspected Colon Polyps, sponsored by Universitätsklinikum Hamburg-Eppendorf. Recruiting at 10 sites in Germany. Open to participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-28.
Sponsored by Universitätsklinikum Hamburg-Eppendorf · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Polyps with a site in Germany — 4 open to participants now, 4 under way, 1 of them phase 3. Polyps · Germany.
Among the 22 studies in Polyps with a site in Germany, this one has the largest planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2020, is one of 11 with no phase, and was the 17th registered.
312 studies on the registry are indexed under Polyps; 59 are open to participants now.
Browse Polyps studies →4 of the 22 studies in Polyps with a site in Germany are open now. Recruiting first, the newest first:
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Sites in Germany
Ages 18+
Rapamycin Holdings Inc. · Sites in Germany, United States, Denmark and 4 more countries
Ages 18+
Helios Kliniken Schwerin · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 34 Polyps studies recruiting now, 25 (74%) set no upper age limit and 6 (18%) stop at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.
This study: 35 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,572 is above the median of 150 across 204 interventional studies indexed under Polyps.
Median enrollment 225 across the 13 interventional studies, 600 across the 9 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 22 have an industry lead sponsor. The 10 most frequent:
Universitätsklinikum Hamburg-Eppendorf is the lead sponsor of 416 studies on the registry; 86 are open to participants now.
Universitätsklinikum Hamburg-Eppendorf has 3 studies filed under Polyps — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 22 studies in Polyps with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Colonoscopy is currently the best method of detection of intestinal tumors and polyps, particularly because polyps can also be biopsied and removed. There is a clear correlation between the adenoma detection rate and prevented carcinomas, so adenoma detection rate is the main parameter for the outcome quality of diagnostic colonoscopy. The efficiency of preventive colonoscopy needs optimisation by increase in adenoma detection rate, as it is known from many studies that approximately 15-30% of all adenomas can be overlooked. This mainly applies to smaller and flat adenomas. However, since even smaller polyps may be relevant for colorectal cancer development, the aim of colonoscopy should be to preferably be able to recognize all polyps and other changes.The latest and by far the most interesting development in this field is the use of artificial intelligence systems. They consist of a switched-on software with a small computer connected to the endoscope processor; the patient's introduced endoscope is completely unchanged.
The present study therefore compares the adenoma detection rate (ADR) of the latest generation of devices with high-resolution imaging from Fujifilm with and without the connection of artificial intelligence.
Methods of Computer Vision (CV) and Artificial Intelligence (AI) provide completely new opportunities, e.g. in the automatic polyp detection and differentiation of a lesion based on its endoscopic image. Computer vision using artificial intelligence methods means the application of "trained" so-called deep neural net (DNN) with a set of defined images (e.g. everyday scenes) and well-known solutions ( e.g. name of the pictured item; c.f. e.g. the "ImageNet Challenge"). The technical feasibility of using AI algorithms in endoscopy has already been proven in many cases. In the present study, it is an AI system from Fujifilm, which is already clinically usable. By using Fujifilm high-resolution imaging devices in colonoscopies, AI will be added randomly.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
colonoscopy with artificial intelligence added
Procedure: colonoscopy
conventional colonoscopy
Procedure: colonoscopy
addition of polyp detection algorithm by Fujifilm
Adenoma detection rate
Difference in adenoma detection rate (all adenomas/all patients) between the two groups
Time frame: during procedure to histological examination result, approximately 2 days
Patient rate difference
Differences in the patient rate with adenomas (adenoma detection rate, i.e. rate of patients with at least one adenoma)
Time frame: during procedure to histological examination result, approximately 2 days
Adenoma subgroup differences
Differences subgroups of adenomas (flat, small, high-grade dysplasia)
Time frame: histological examination result, approximately 2 days
rate of hyperplastic polyp detection in both groups
Differences in the detection of hyperplastic polyps
Time frame: histological examination result, approximately 2 days
rate of polyp detection in preventive and diagnostic colonoscopy
Differences in preventive vs. diagnostic colonoscopy
Time frame: during procedure to histological examination result, approximately 2 days
Switching number (BLI, LCI) in both groups
number of switches to visual support by colour filters
Time frame: during procedure
incidence of reasons for switching to BLI/LCI
reasons for switching to visual support by colour filters
Time frame: during procedure
quality of polyp detection rate by image evaluation
differential diagnosis of colon polyps in both groups with/without CADEYE)
Time frame: until 2 months after recruitment stop
Not enrolling at this site.
Not enrolling at this site.
Plan to share: No
Started Oct 2020 (actual). Primary completion is estimated for May 2024, 43 months after the start.
Of 68 non-industry interventional studies with no phase under Polyps, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 43 months is above that.
Counting every sponsor, half of 79 studies reached it within 23 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsklinikum Hamburg-Eppendorf →